Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Lupin and Natco FDA approval puts #LUPIN in focus as oncology generic pipeline strengthens Lupin and Natco won FDA approval for Eribulin generic. #LUPIN investors now face the real test: launch timing and U.S. pricing. byVenkateshJune 5, 2026